Chen et al. found a sensitivity of 40.9% and specificity of 86.6% for CEA in CRC and when combined with survivin antibodies the sensitivity rises to 51.3% and the specificity to 89.9% [10]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.